Type of event: | Performance |
Start time: | 6:55pm |
Duration: | 10 Minutes |
External website related to this event: | asoft4201.accrisoft.com/mlcc/index.php?src=sba&srctype=geteventdetails&cale_id=1014&function_code=RD2019 |
Venue: | Drexelbrook Hotel & Special Event Center 4700 Drexelbrook Dr Drexel Hill, PA 19026 |
Description: | DETAILS: 5:30 pm Cocktail Reception 6:30 pm Dinner / Program KEYNOTE SPEAKER: Jeff Marrazzo CEO & Co-Founder, Spark Therapeutics Nearly two decades ago, the mapping of the human genome promised to break the code to disease prevention. It wasn't until two years ago, however, that a Philadelphia company pioneered the first FDA-approved gene therapy to cure a genetic disease - allowing sufferers of a specific type of blindness to see after only a single dose. Jeff Marrazzo, CEO and Co-Founder of Spark Therapeutics, the company behind this revolutionary cure, will talk about the future of medicine, the price of cure and the work being done by drug discovery companies in Greater Philadelphia. Marrazzo and his company's commitment to the region remains steadfast as it is under agreement to be purchased by Roche, the world's largest biotech company, in a $4.3 billion deal that will allow Spark to continue its work as a core part of Philadelphia's science hub. PRESENTING SPONSOR: RECEPTION SPONSORS: BNY Mellon Drexelbrook Hotel & Special Event Center HSBC Bank Independence Blue Cross JP Morgan VISIONARY SPONSORS: Closets by Design Enterprise Holdings Firstrust Vanguard Wells Fargo LEADER SPONSORS: Aqua BB&T Berkshire Hathaway HomeServices Fox & Roach, REALTORS Brinker Simpson & Co. Harcum College Haverford Trust Company JP Morgan Chase Bank Kaplin Stewart Meloff Reiter & Stein, P.C. KYW Newsradio Main Line Today Minuteman Press Nolan Painting Peirce College Riley Riper Hollin & Colagreco Sabre Systems Stephen J. DiOrio, CLU, ChFC, Agency, State Farm Stradley Ronon Stevens & Young, LLP TD Bank UGI Amerigas UnitedHealthcare WSFS Bank |